The global Diabetes Pen Market was valued at USD 5.86 billion in 2016 and is projected to reach USD 11.19 billion by 2025, growing at a CAGR of 7.45% from 2017 to 2025.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. The increasing prevalence of diabetic patients all over the globe paired with increasing geriatric population are some drivers to the market.
1. Market Drivers
1.1 Growth in prevalence of diabetes cases in varied age group
1.2 Growth in product launches
1.3 Promising regulations
1.4 Growth in awareness amongst people
2. Market Restraints
2.1 Increased R&D investments.
2.2 Safety issues related to reusable injection pen restrain the market
1. Global Diabetes Pen Market, by Indication:
1.1 type I diabetes
1.2 type II diabetes
Click and ask for the lucrative Discount@ WMR – https://westernmarketresearch.com/market-report/332/Global-Diabetes-Pen-Market-Size-And-Forecast-To-20#inquiry
2. Global Diabetes Pen Market, by ProductType:
2.1 Insulin Pens
2.2 Insulin pen needles
3. Global Diabetes Pen Market, by Types:
4. Global Diabetes Pen Market, by Therapies:
4.2 glucagon-like peptide-1
4.3 growth hormones
5. Global Diabetes Pen Market, by End User:
5.3 home care settings
6. Global Diabetes Pen Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Buy this Report Now – https://westernmarketresearch.com/buynow.php?id=332
The major players in the market are as follows:
1. Astra Zeneca
3. Eli Lilly and Company
6. Jiangsu Delfu medical device Co.,Ltd.
7. Owen Mumford Ltd.
9. Smiths Group plc.
10. P&B Pharmaceuticals Ltd.
11. NIPRO Medical Corporation
12. Novo Nordisk A/S
13. Injex UK
14. Mannkind Corporation
Read in Details click on below – https://westernmarketresearch.com/market-report/332/Global-Diabetes-Pen-Market-Size-And-Forecast-To-20